Skip to main content
OpenTrials
Completed

NCT Number: NCT05118152

Correlation Between 3D Echocardiography and Cardiopulmonary Exercise Testing in Patients With Single Ventricle

Congenital heart disease (CHD) is the leading cause of birth defects, with an incidence of 0.8%. Among CHD, univentricular heart disease or "single ventricle" is rare and complex. As a result of the improved patient care over the last decades, the number of children and adults with single ventricle is increasing significantly. Today, the main challenge is to ensure an optimal follow-up of these new patients in order to improve their life expenctancy as well as their quality of life (QoL). Currently, echocardiography and cardiopulmonary exercice test (CPET) are central in management of patients with single ventricle as part of good clinical practice guidelines.

Single ventricle volumes and function are very difficult to asses with conventional echocardiography because of their complex geometry. Indeed, single ventricle size and morphology vary depending on the patient characteristics and on the initial CHD (before surgical repair). That's why conventional 2D echocardiographic parameters are not reliable for single ventricle assessment.

Magnetic resonance imaging (MRI) is more effective in assessing single ventricle volumes and function. Nevertheless, MRI is not universally available, is not practical in many situations, is expensive, and is a relative contraindication in patients with pacemakers.

Over the past decade, the use of the 3D echocardiography has increased. This is an available tool that can assess ventricular function and volumes in few seconds. Recent studies shown a good correlation between 3D echocardiography and MRI for assessment of ventricular volumes and function in patient with CHD and especially in those with single ventricle.

Moreover, according to some authors, CPET parameters are strongly correlated with risk of hospitalization, risk of death, physical activity and quality of life, especially in patients with single ventricle.

To date, there is no study performed about the relationship between 3D echocardiography and CPET parameters in patients with single ventricle.

Completed

Looking for future studies?

Notify Me

Key information

Age range

8 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Uh Montpellier

Montpellier, 34295, France

About this study

This is a cross-sectional, observational, multicenter, and prospective study Eligible patients will be included during their usual medical check-up. As recommended by guidelines, patients with single ventricle have an 2D echocardiography and a CPET annualy. Data required for this study will be collected from patient medical record.

3D echography data acquisition will be performed using 2D ultrasound post-processing by TOMTEC software. No supplementary visit, directly related to the research, will be necessary. This study does not change the usual care management of the patient.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient over 8 years old with univentricular heart disease as defined by the ACC-CHD classification
  • Agreement from adults or parents if minor patients
  • CPET performed within the 6 months before or after performing echocardiography

Exclusion criteria

  • Cardiomyopathy unrelated to CHD (eg coronary artery disease, toxic cardiomyopathy)
  • Significant clinical status change between performing CPET and performing echocardiography, according to the investigator's opinion

Treatment and study plan

Primary outcomes

  1. Association between single ventricle volumes and function parameters in 3D echocardiography

    Time frame: day 1

    Association between single ventricle volumes and function parameters in 3D echocardiography (End-diastolic volume, End-systolic volume, Stroke volume)

Secondary outcomes

  1. Association between 3D echocardiography and clinical data collected

    Time frame: day 1

    Association between 3D echocardiography and clinical data collected in usual medical check-up.

  2. Association between 3D echocardiography and quality of life data usually collected

    Time frame: day 1

    Association between 3D echocardiography and quality of life data usually collected.

  3. ssociation between 3D echocardiography and 2D echocardiography data usually collected

    Time frame: day 1

    Association between 3D echocardiography and 2D echocardiography data usually collected.

  4. Association between 3D echocardiography and blood test data usually collected.

    Time frame: day 1

    Association between 3D echocardiography and blood test data usually collected.

  5. Association between 3D echocardiography and MRI data usually collected.

    Time frame: day 1

    Association between 3D echocardiography and MRI data usually collected.

  6. Assessment of 3D echocardiography interobserver and intraobserver variability

    Time frame: day 1

    Assessment of 3D echocardiography interobserver and intraobserver variability.

Sponsors and collaborators

Lead sponsor

University Hospital, Montpellier

Other

Collaborators

  • University Hospital, Bordeaux

Registry information

Official study title

Correlation Between 3D Echocardiography and Cardiopulmonary Exercise Testing in Patients With Single Ventricle: A Cross-sectional Observational Multicenter Prospective Study

Acronym: VU3D

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Nov 11, 2021
Registry last updated
Oct 27, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.